• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ARTEMISININ Drug Record

  • Summary
  • Interactions
  • Claims
  • ARTEMISININ chembl:CHEMBL567597 Approved

    Alternate Names:

    ARTEMISIN
    ARTEMISININ
    GNF-PF-5341
    (+)-ARTEMISININ
    NSC-369397

    Drug Info:

    (0 More Sources)

    Publications:

    Lang T et al., 2001, Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver., Pharmacogenetics
    Zanger UM et al., 2007, Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance., Pharmacogenomics
    Simonsson US et al., 2003, Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9., Clin Pharmacol Ther
    Kerb R et al., 2009, Pharmacogenetics of antimalarial drugs: effect on metabolism and transport., Lancet Infect Dis
    Medhi B et al., 2009, Pharmacokinetic and toxicological profile of artemisinin compounds: an update., Pharmacology
    Veiga MI et al., 2009, Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam., Eur J Clin Pharmacol
    Elsherbiny DA et al., 2008, A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens., J Pharmacokinet Pharmacodyn
    Asimus S et al., 2008, Artemisinin and CYP2A6 activity in healthy subjects., Eur J Clin Pharmacol
    Li XQ et al., 2003, Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data., Eur J Clin Pharmacol
  • ARTEMISININ   CYP2A6

    Interaction Score: 2.94

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12844133 19926036 19851082 18979093 18350255 18064444 12920490


    Sources:
    PharmGKB

  • ARTEMISININ   ATP2A1

    Interaction Score: 0.98

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • ARTEMISININ   CYP2B6

    Interaction Score: 0.55

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11470993 17638512


    Sources:
    PharmGKB

  • ARTEMISININ   NR1I2

    Interaction Score: 0.08

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • ARTEMISININ   TARDBP

    Interaction Score: 0.08

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ARTEMISININ   ALDH1A1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • ARTEMISININ   CYP3A4

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • PharmGKB: artemisinin

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Zanger UM et al., 2007, Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance., Pharmacogenomics
    Lang T et al., 2001, Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver., Pharmacogenetics
    Asimus S et al., 2008, Artemisinin and CYP2A6 activity in healthy subjects., Eur J Clin Pharmacol

  • DTC: ARTEMISININ

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL567597 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Artemisinin

    • Version: 2020.06.01

    Alternate Names:
    D0S3WH TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL567597

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21